Intimal hyperplasia is a major cause of restenosis that occurs at an unacceptably high rate, particularly in peripheral vascular beds. Based on our findings made in a rat carotid injury model, we put forward an unconventional hypothesis that apoptosis of vascular smooth muscle cells (SMCs) induced by primary vascular intervention influences the entire vessel wall including intimal endothelial cells as well as cells of the arteral adventitia. Our data suggest that SMCs signal to the adventitia and endothelium through protein kinase C-delta (PKCd)-dependent production of chemokines. We have identified MCP-1 as a critical paracrine factor through which SMCs modulate adventitial fibroblasts. By combining PKCd gene transfer with an MCP-1 neutralizing antibody, we blocked fibroblasts from migrating into the intima and doubled the inhibitory effect of PKCd on IH. However, the mechanism underlying acceleration of re-endothelialization remains unclear.
In Specific Aim I, we plan to test the hypothesis that apoptotic SMCs stimulate re- endothelialization by driving recruitment of bone marrow-derived cells which in turn contribute to endothelial regeneration through differentiation or paracrine effects. We will also test whether CXCL7 underlies the recruitment of pro-endothelial cells.
In Specific Aim II, we will test whether the paracrine effects produced by PKCd-expressing SMCs are general properties of apoptotic cells. In vitro, we will examine whether induction of apoptosis with physiologically relevant stimuli such as oxidative stress and cytokines produce paracrine factors that attract adventitial fibroblasts or bone marrow-derived circulating proangiogenic cells. In vivo, we will drive arterial smooth muscle cells to apoptosis b expressing human diphtheria toxin receptor with an expectation that enhanced apoptosis will reduce SMC accumulation, stimulate migration of adventitial fibroblasts but accelerate re-endothelialization.
In Specific Aim III, we will attempt to translate the PKCd modifications we developed in preliminary studies to attenuate intimal hyperplasia by stimulating apoptosis and re- endothelialization but suppressing influx of adventitial fibroblasts. In summary, this is a significant and highly translational project that is likely to expand our knowledge on cell death and therapeutic development.
Our recent discoveries on the paracrine functions of apoptosis revealed a new crosstalk between vascular smooth muscle cells and other cell types in the vessel wall. One form of the cell-cell crosstalk worsens intimal hyperplasia, the thickening of vessel wall, while other forms limit intimal growth. This research will provide avenues to design innovative therapeutic intervention to treat or prevent intimal hyperplasia, and therefore improve the long-term efficacy of angioplasty, stenting and bypass surgeries.
| Gupta, Kartik; Phan, Noel; Wang, Qiwei et al. (2018) Necroptosis in cardiovascular disease - a new therapeutic target. J Mol Cell Cardiol 118:26-35 |
